Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: A study of 77 cases

Kaiyong Mei, Aijun Liu, Robert W. Allan, Peng Wang, Zhaoli Lane, Ty W. Abel, Lixin Wei, Hong Cheng, Shuangping Guo, Yan Peng, Dinesh Rakheja, Min Wang, Joe Ma, Maria Rodriguez, Jianping Li, Dengfeng Cao

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Primary germ cell tumors of the central nervous system (CNS) sometimes pose diagnostic difficulty. In this study we analyzed the diagnostic utility of a novel marker, SALL4, in 77 such tumors (59 pure and 18 mixed) consisting of the following tumors/tumor components: 49 germinomas, 7 embryonal carcinomas, 27 yolk sac tumors, 3 choriocarcinomas, and 14 teratomas. We also stained SALL4 in 99 primary non-germ cell tumors to test SALL4 specificity. We compared SALL4 with OCT4 in all germ cell tumors and compared SALL4 with α-fetoprotein and glypican-3 in all yolk sac tumors. The staining was semiquantitatively scored as 0 (no staining), 1 (30%), 2(31-60%), 3 (61-90%), and 4 (90%). Strong SALL4 staining was observed in all 49 germinomas (4 in 48, 3 in 1), 7 embryonal carcinomas (all 4), and 27 yolk sac tumors (1 in 1, 2 in 2, 3 in 7, 4 in 17). SALL4 staining, 1 weak to focally strong, was observed in 2 of 3 choriocarcinomas (in mononucleated trophoblasts) and in 9 of 14 teratomas (in primitive neuroepithelium and teratomatous glands). All germinomas and embryonal carcinomas showed strong OCT4 staining (4 in all except 1 germinoma with 3), whereas other germ cell tumors were negative. Out of 27 yolk sac tumors, 26 showed positive α-fetoprotein staining (1 in 9, 2 in 7, 3 in 5, and 4 in 5). All yolk sac tumors showed positive glypican-3 staining (1 in 6, 2 in 6, 3 in 7, and 4 in 8). The mean percentage of yolk sac tumor cells stained was 84% with SALL4, 45% with α-fetoprotein, and 63% with glypican-3 (P0.01). No non-germ cell tumors showed SALL4 staining. Our results indicate that SALL4 is a novel sensitive diagnostic marker for primary germ cell tumors of the CNS with high specificity. SALL4 is a more sensitive marker than α-fetoprotein and glypican-3 for yolk sac tumors.

Original languageEnglish
Pages (from-to)1628-1636
Number of pages9
JournalModern Pathology
Volume22
Issue number12
DOIs
StatePublished - Dec 1 2009

Fingerprint

Nervous System Neoplasms
Endodermal Sinus Tumor
Germ Cell and Embryonal Neoplasms
Central Nervous System
Glypicans
Germinoma
Fetal Proteins
Staining and Labeling
Embryonal Carcinoma
Choriocarcinoma
Teratoma
Neoplasms
Trophoblasts

Keywords

  • Central nervous system
  • Diagnostic marker
  • Germ cell tumors
  • SALL4

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system : A study of 77 cases. / Mei, Kaiyong; Liu, Aijun; Allan, Robert W.; Wang, Peng; Lane, Zhaoli; Abel, Ty W.; Wei, Lixin; Cheng, Hong; Guo, Shuangping; Peng, Yan; Rakheja, Dinesh; Wang, Min; Ma, Joe; Rodriguez, Maria; Li, Jianping; Cao, Dengfeng.

In: Modern Pathology, Vol. 22, No. 12, 01.12.2009, p. 1628-1636.

Research output: Contribution to journalArticle

Mei, K, Liu, A, Allan, RW, Wang, P, Lane, Z, Abel, TW, Wei, L, Cheng, H, Guo, S, Peng, Y, Rakheja, D, Wang, M, Ma, J, Rodriguez, M, Li, J & Cao, D 2009, 'Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: A study of 77 cases', Modern Pathology, vol. 22, no. 12, pp. 1628-1636. https://doi.org/10.1038/modpathol.2009.148
Mei, Kaiyong ; Liu, Aijun ; Allan, Robert W. ; Wang, Peng ; Lane, Zhaoli ; Abel, Ty W. ; Wei, Lixin ; Cheng, Hong ; Guo, Shuangping ; Peng, Yan ; Rakheja, Dinesh ; Wang, Min ; Ma, Joe ; Rodriguez, Maria ; Li, Jianping ; Cao, Dengfeng. / Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system : A study of 77 cases. In: Modern Pathology. 2009 ; Vol. 22, No. 12. pp. 1628-1636.
@article{cbc91c9140fa4a249964acbc4c977143,
title = "Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: A study of 77 cases",
abstract = "Primary germ cell tumors of the central nervous system (CNS) sometimes pose diagnostic difficulty. In this study we analyzed the diagnostic utility of a novel marker, SALL4, in 77 such tumors (59 pure and 18 mixed) consisting of the following tumors/tumor components: 49 germinomas, 7 embryonal carcinomas, 27 yolk sac tumors, 3 choriocarcinomas, and 14 teratomas. We also stained SALL4 in 99 primary non-germ cell tumors to test SALL4 specificity. We compared SALL4 with OCT4 in all germ cell tumors and compared SALL4 with α-fetoprotein and glypican-3 in all yolk sac tumors. The staining was semiquantitatively scored as 0 (no staining), 1 (30{\%}), 2(31-60{\%}), 3 (61-90{\%}), and 4 (90{\%}). Strong SALL4 staining was observed in all 49 germinomas (4 in 48, 3 in 1), 7 embryonal carcinomas (all 4), and 27 yolk sac tumors (1 in 1, 2 in 2, 3 in 7, 4 in 17). SALL4 staining, 1 weak to focally strong, was observed in 2 of 3 choriocarcinomas (in mononucleated trophoblasts) and in 9 of 14 teratomas (in primitive neuroepithelium and teratomatous glands). All germinomas and embryonal carcinomas showed strong OCT4 staining (4 in all except 1 germinoma with 3), whereas other germ cell tumors were negative. Out of 27 yolk sac tumors, 26 showed positive α-fetoprotein staining (1 in 9, 2 in 7, 3 in 5, and 4 in 5). All yolk sac tumors showed positive glypican-3 staining (1 in 6, 2 in 6, 3 in 7, and 4 in 8). The mean percentage of yolk sac tumor cells stained was 84{\%} with SALL4, 45{\%} with α-fetoprotein, and 63{\%} with glypican-3 (P0.01). No non-germ cell tumors showed SALL4 staining. Our results indicate that SALL4 is a novel sensitive diagnostic marker for primary germ cell tumors of the CNS with high specificity. SALL4 is a more sensitive marker than α-fetoprotein and glypican-3 for yolk sac tumors.",
keywords = "Central nervous system, Diagnostic marker, Germ cell tumors, SALL4",
author = "Kaiyong Mei and Aijun Liu and Allan, {Robert W.} and Peng Wang and Zhaoli Lane and Abel, {Ty W.} and Lixin Wei and Hong Cheng and Shuangping Guo and Yan Peng and Dinesh Rakheja and Min Wang and Joe Ma and Maria Rodriguez and Jianping Li and Dengfeng Cao",
year = "2009",
month = "12",
day = "1",
doi = "10.1038/modpathol.2009.148",
language = "English",
volume = "22",
pages = "1628--1636",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system

T2 - A study of 77 cases

AU - Mei, Kaiyong

AU - Liu, Aijun

AU - Allan, Robert W.

AU - Wang, Peng

AU - Lane, Zhaoli

AU - Abel, Ty W.

AU - Wei, Lixin

AU - Cheng, Hong

AU - Guo, Shuangping

AU - Peng, Yan

AU - Rakheja, Dinesh

AU - Wang, Min

AU - Ma, Joe

AU - Rodriguez, Maria

AU - Li, Jianping

AU - Cao, Dengfeng

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Primary germ cell tumors of the central nervous system (CNS) sometimes pose diagnostic difficulty. In this study we analyzed the diagnostic utility of a novel marker, SALL4, in 77 such tumors (59 pure and 18 mixed) consisting of the following tumors/tumor components: 49 germinomas, 7 embryonal carcinomas, 27 yolk sac tumors, 3 choriocarcinomas, and 14 teratomas. We also stained SALL4 in 99 primary non-germ cell tumors to test SALL4 specificity. We compared SALL4 with OCT4 in all germ cell tumors and compared SALL4 with α-fetoprotein and glypican-3 in all yolk sac tumors. The staining was semiquantitatively scored as 0 (no staining), 1 (30%), 2(31-60%), 3 (61-90%), and 4 (90%). Strong SALL4 staining was observed in all 49 germinomas (4 in 48, 3 in 1), 7 embryonal carcinomas (all 4), and 27 yolk sac tumors (1 in 1, 2 in 2, 3 in 7, 4 in 17). SALL4 staining, 1 weak to focally strong, was observed in 2 of 3 choriocarcinomas (in mononucleated trophoblasts) and in 9 of 14 teratomas (in primitive neuroepithelium and teratomatous glands). All germinomas and embryonal carcinomas showed strong OCT4 staining (4 in all except 1 germinoma with 3), whereas other germ cell tumors were negative. Out of 27 yolk sac tumors, 26 showed positive α-fetoprotein staining (1 in 9, 2 in 7, 3 in 5, and 4 in 5). All yolk sac tumors showed positive glypican-3 staining (1 in 6, 2 in 6, 3 in 7, and 4 in 8). The mean percentage of yolk sac tumor cells stained was 84% with SALL4, 45% with α-fetoprotein, and 63% with glypican-3 (P0.01). No non-germ cell tumors showed SALL4 staining. Our results indicate that SALL4 is a novel sensitive diagnostic marker for primary germ cell tumors of the CNS with high specificity. SALL4 is a more sensitive marker than α-fetoprotein and glypican-3 for yolk sac tumors.

AB - Primary germ cell tumors of the central nervous system (CNS) sometimes pose diagnostic difficulty. In this study we analyzed the diagnostic utility of a novel marker, SALL4, in 77 such tumors (59 pure and 18 mixed) consisting of the following tumors/tumor components: 49 germinomas, 7 embryonal carcinomas, 27 yolk sac tumors, 3 choriocarcinomas, and 14 teratomas. We also stained SALL4 in 99 primary non-germ cell tumors to test SALL4 specificity. We compared SALL4 with OCT4 in all germ cell tumors and compared SALL4 with α-fetoprotein and glypican-3 in all yolk sac tumors. The staining was semiquantitatively scored as 0 (no staining), 1 (30%), 2(31-60%), 3 (61-90%), and 4 (90%). Strong SALL4 staining was observed in all 49 germinomas (4 in 48, 3 in 1), 7 embryonal carcinomas (all 4), and 27 yolk sac tumors (1 in 1, 2 in 2, 3 in 7, 4 in 17). SALL4 staining, 1 weak to focally strong, was observed in 2 of 3 choriocarcinomas (in mononucleated trophoblasts) and in 9 of 14 teratomas (in primitive neuroepithelium and teratomatous glands). All germinomas and embryonal carcinomas showed strong OCT4 staining (4 in all except 1 germinoma with 3), whereas other germ cell tumors were negative. Out of 27 yolk sac tumors, 26 showed positive α-fetoprotein staining (1 in 9, 2 in 7, 3 in 5, and 4 in 5). All yolk sac tumors showed positive glypican-3 staining (1 in 6, 2 in 6, 3 in 7, and 4 in 8). The mean percentage of yolk sac tumor cells stained was 84% with SALL4, 45% with α-fetoprotein, and 63% with glypican-3 (P0.01). No non-germ cell tumors showed SALL4 staining. Our results indicate that SALL4 is a novel sensitive diagnostic marker for primary germ cell tumors of the CNS with high specificity. SALL4 is a more sensitive marker than α-fetoprotein and glypican-3 for yolk sac tumors.

KW - Central nervous system

KW - Diagnostic marker

KW - Germ cell tumors

KW - SALL4

UR - http://www.scopus.com/inward/record.url?scp=71149088322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71149088322&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2009.148

DO - 10.1038/modpathol.2009.148

M3 - Article

C2 - 19820689

AN - SCOPUS:71149088322

VL - 22

SP - 1628

EP - 1636

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 12

ER -